12. ANALYSIS OF SOME RISK FACTORS ASSOCIATED WITH DRUG-RESISTANT EPILEPSY IN CHILDREN
Main Article Content
Abstract
Objective: Identify some risk factors for drug-resistant epilepsy in children.
Subjects and methods: Cross-sectional descriptive study on 100 children with epilepsy. including 46 females (46%) and 54 males (54%), divided into 2 groups: drug-resistant epilepsy group (n = 50) and drug-responsive epilepsy group (n = 50), diagnostic criteria according to the International Association against Epilepsy (ILAE 2010).
Results: Drug-resistant epilepsy with a history of status epilepticus accounted for 30%, neonatal seizures accounted for 22%, febrile seizures accounted for 44%, psychomotor retardation accounted for 92%. The average age of onset in the drug-resistant epilepsy group was 17.3 ± 13 months, the average frequency of seizures per day was 12 ± 8. Generalized epilepsy accounted for 74% of both study groups. There were 18 cases classified as syndrome, accounting for 18%. Paraclinical results of electrostatic discharge and brain MRI were abnormal in drug-resistant and responsive epilepsy groups, accounting for 94% and 30%, respectively. Regression analysis of results: Neonatal seizures, febrile seizures, history of status epilepticus, delayed psychomotor development, abnormal electroencephalogram and MRI are factors related to epilepsy.
Conclusion: Patients with a history of neonatal seizures, a history of febrile seizures, a history of status epilepticus, psychomotor retardation, abnormal electroencephalogram and brain MRI are risk factors. associated with drug-resistant epilepsy.
Article Details
Keywords
Children, epilepsy, drug-resistant epilepsy.
References
onset epilepsy over the first two decades: a93
prospective, longitudinal study; Epilepsia, 56(1),
2015, 40-48.
[2] Berg AT, Shinnar S, Levy SR, Early development
of intractable epilepsy in children: a prospective
study; Neurology, 56(11), 2001, 1445-1452.
[3] Kwan P, Arzimanoglou A, Berg AT, Definition
of drug resistant epilepsy: Consensus proposal by
the ad hoc Task Force of the ILAE Commission
on Therapeutic Strategies; Epilepsia, 51(6),
2010, 1069-1077.
[4] Laxer KD, Trinka E, Hirsch LJ, The consequences
of refractory epilepsy and its treatment; Epilepsy
& Behavior, 37, 2014, 59-70.
[5] Tang F, Hartz AMS, Bauer B, Drug-Resistant
Epilepsy: Multiple Hypotheses, Few Answers;
Frontiers in Neurology, 8, 2017.
[6] Trinka E, Bauer G, Oberaigner W, Cause
specific mortality among patients with epilepsy:
Results from a 30-year cohort study; Epilepsia,
54(3), 2013, 495-501.
[7] Vickers NJ, Animal communication: when
i’m calling you, will you answer too? Current
biology, 27(14), 2017, R713-R715.
[8] Boonluksiri P, Visuthibhan A, Katanyuwong
K, Clinical Prediction Rule of Drug Resistant
Epilepsy in Children; J Epilepsy Res, 5(2), 2015, 84-88.
[9] Kasprzyk M, Brola W, Wendorff J, Assessment
of clinical risk factors for drug-resistant epilepsy
in children and teenagers; Studia Medyczne, 3,
2014, 141-147.
[10] Nguyễn Thụy Minh Thư, Nguyễn Lê Trung
Hiếu, Mức độ khả thi, an toàn và hiệu quả của
chế độ ăn Ketogenic trên bệnh nhân động kinh
kháng thuốc tại Bệnh viện Nhi Đồng 2; Tạp chí
Y học TP Hồ Chí Minh, tập 25, số 2, 2021.
[11] Trang Thị Hoàng Mai, Lê Thị Khánh Vân,
Nguyễn Lê Trung Hiếu, Yếu tố nguy cơ kháng
thuốc trong điều trị động kinh ở trẻ em tại Bệnh
viện Nhi Đồng 2; Tạp chí Y học Thành phố Hồ
Chí Minh, tập 23, số 3, 2019.
[12] Kwan P, Arzimanoglou A, Berg AT, Definition
of drug resistant epilepsy: consensus proposal by
the ad hoc Task Force of the ILAE Commission
on Therapeutic Strategies, Epilepsia. 2010
Sep;51(9):1922.
[13] Patil MG, Malik S, Joshi S, Early predictors of
intractable childhood epilepsy; Bombay Hospital
Journal, 51(1), 2009, 37.
[14] Yilmaz BS, Okuyaz C, Komur M, Predictors
of intractable childhood epilepsy; Pediatric
neurology, 48(1), 2013, 52-55.
[15] Sporiš D, Bašić S, Šušak I, Predictive factors
for early identification of pharmacoresistant
epilepsy; Acta clinica Croatica, 52(1), 2013, 11-15.
[16] Karaoğlu P, Yi̇ Ş U, Polat Aİ, Clinical predictors
of drug-resistant epilepsy in children; Turk J
Med Sci, 51(3), 2021, 1249-1252.
[17] Altunbasak S, Herguner O, Burgut HR, Risk
factors predicting refractoriness in epileptic
children with partial seizures; Journal of child
neurology, 22(2), 2007, 195-199.
[18] Đặng Anh Tuấn, Nghiên cứu lâm sàng, tổn
thương não và các yếu tố liên quan đến động
kinh cục bộ kháng thuốc ở trẻ em; Luận án tiến
sỹ y học, Đại học Y Hà Nội, 2018.
[19] Wong M, Trevathan E, Infantile spasms;
Pediatric neurology, 24(2), 2001, 89-98.
[20] Arafa MA, Fathy MM, Siam AG, Predictors of
drug resistant epilepsy in children: a clinical,
electroencephalographic and neuroimaging
dtudy; Zagazig University Medical Journal,
17(2), 2015.
[21] Mohanraj R, Brodie MJ, Early predictors of
outcome in newly diagnosed epilepsy; Seizure,
22(5), 2013, 333-344